PAHO supports the Dominican Republic in strengthening efforts to eliminate bacterial meningitis as a public health problem - Pan American Health Organization (PAHO)
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Santo Domingo, Dominican Republic — The Pan American Health Organization (PAHO), in collaboration with national health authorities, conducted a technical mission from 14 to 17 September 2026 to support the country’s progress towards the goals of the global road map to defeat meningitis by 2030 and advance regional and national efforts to eliminate bacterial meningitis as a public health problem. The mission brought together national teams in epidemiology, laboratory services, clinical care, immunization and health promotion, alongside PAHO specialists and international experts. Activities included a multidisciplinary national workshop, visits to public health facilities of the Ministry of Health and the National Health Service in Santo Domingo and Santiago de los Caballeros, and technical exchanges at the Dr. Defilló National Reference Laboratory. Building on the country’s existing surveillance systems, laboratory capacity and committed health teams, participants identified practical opportunities to strengthen the continuum of care, from early recognition and timely diagnosis to treatment, notification and follow-up for people affected by meningitis.
This article is an excerpt. To read the full content, visit the original source. Pan American Health Organization (PAHO)
Related articles
Strengthening public health decision-making using surveillance data in the ‘meningitis belt’ - Dalla Lana School of Public Health
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!